BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38537553)

  • 21. Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses.
    Andreassen PR; Seo J; Wiek C; Hanenberg H
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356050
    [No Abstract]   [Full Text] [Related]  

  • 22. The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice.
    Stucci LS; InternĂ² V; Tucci M; Perrone M; Mannavola F; Palmirotta R; Porta C
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34068084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fears and barriers: problems in breast cancer diagnosis and treatment in Pakistan.
    Saeed S; Asim M; Sohail MM
    BMC Womens Health; 2021 Apr; 21(1):151. PubMed ID: 33853583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer.
    Algebaly AS; Suliman RS; Al-Qahtani WS
    Clin Transl Oncol; 2021 Jan; 23(1):74-81. PubMed ID: 32451972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathways to care for patients in Pakistan experiencing signs or symptoms of breast cancer.
    Hameed Khaliq I; Mahmood HZ; Sarfraz MD; Masood Gondal K; Zaman S
    Breast; 2019 Aug; 46():40-47. PubMed ID: 31075671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological characteristics of and risk factors for breast cancer in the world.
    Momenimovahed Z; Salehiniya H
    Breast Cancer (Dove Med Press); 2019; 11():151-164. PubMed ID: 31040712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying the reasons for delayed presentation of Pakistani breast cancer patients at a tertiary care hospital.
    Gulzar F; Akhtar MS; Sadiq R; Bashir S; Jamil S; Baig SM
    Cancer Manag Res; 2019; 11():1087-1096. PubMed ID: 30774437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
    Smith IN; Thacker S; Jaini R; Eng C
    J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan.
    Sarwar MR; Iftikhar S; Saqib A
    BMC Cancer; 2018 Jan; 18(1):14. PubMed ID: 29298681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development.
    Mehrgou A; Akouchekian M
    Med J Islam Repub Iran; 2016; 30():369. PubMed ID: 27493913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer Agreement.
    Ali A; Bell S; Bilsland A; Slavin J; Lynch V; Elgoweini M; Derakhshan MH; Jamieson NB; Chang D; Brown V; Denley S; Orange C; McKay C; Carter R; Oien KA; Duthie FR
    Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):599-608. PubMed ID: 27093449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond BRCA: new hereditary breast cancer susceptibility genes.
    Economopoulou P; Dimitriadis G; Psyrri A
    Cancer Treat Rev; 2015 Jan; 41(1):1-8. PubMed ID: 25467110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.
    Shahid T; Soroka J; Kong E; Malivert L; McIlwraith MJ; Pape T; West SC; Zhang X
    Nat Struct Mol Biol; 2014 Nov; 21(11):962-968. PubMed ID: 25282148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fast and accurate long-read alignment with Burrows-Wheeler transform.
    Li H; Durbin R
    Bioinformatics; 2010 Mar; 26(5):589-95. PubMed ID: 20080505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.
    Evans DG; Shenton A; Woodward E; Lalloo F; Howell A; Maher ER
    BMC Cancer; 2008 May; 8():155. PubMed ID: 18513387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
    Musolino A; Naldi N; Michiara M; Bella MA; Zanelli P; Bortesi B; Capelletti M; Savi M; Neri TM; Ardizzoni A
    Breast Cancer Res Treat; 2005 May; 91(2):203-5. PubMed ID: 15868448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 and BRCA2: 1994 and beyond.
    Narod SA; Foulkes WD
    Nat Rev Cancer; 2004 Sep; 4(9):665-76. PubMed ID: 15343273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linkage of early-onset familial breast cancer to chromosome 17q21.
    Hall JM; Lee MK; Newman B; Morrow JE; Anderson LA; Huey B; King MC
    Science; 1990 Dec; 250(4988):1684-9. PubMed ID: 2270482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan.
    Ahmad H; Ali A; Ali R; Khalil AT; Khan I; Khan MM; Alorini M
    Neoplasia; 2024 May; 51():100989. PubMed ID: 38537553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.